Remove Networking Remove Patients Remove Physicians Remove Safety
article thumbnail

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

Legacy MEDSearch

In addition, pooled analysis results from the combined primary efficacy endpoint and safety data from RADIANCE SOLO, RADIANCE TRIO, and RADIANCE II were concurrently published in JAMA Cardiology. Patients were to remain off antihypertensive medications throughout the two months of follow-up unless specified BP criteria were exceeded.

article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.

Safety 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

Precision-based Targeting: A Better Way to Connect with Patients and Healthcare Professionals

LEVO Health

Traditionally, healthcare marketing relied on broad, generalized strategies that often missed the mark in addressing the unique needs of diverse patient populations and high-level healthcare professionals (HCPs). While the one-size-fits-all approach had a broad reach, it lacked the precision necessary for impactful engagement.

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Leads 52
article thumbnail

Using data analytics to better manage care transitions

Clarify Health

Care transitions are often critical periods where patients may be vulnerable to complications or relapses. Ensuring effective management of care transitions is not just a matter of patient convenience; it is pivotal to enhancing patient outcomes, improving population health, and reducing unnecessary medical spend.

article thumbnail

UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient

Legacy MEDSearch

UroMems , a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it has successfully completed the first-ever implant of the UroActive smart, automated artificial urinary sphincter (AUS) in a female patient. Food and Drug Administration).